Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
MDCX Quote, Financials, Valuation and Earnings
Last price:
$3.23
Seasonality move
:
-0.57%
Day range:
$2.93 - $3.15
52-week range:
$1.80 - $12.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
22.48x
Volume:
376.2K
Avg. volume:
445.6K
1-year change:
-57.2%
Market cap:
$48.3M
Revenue:
--
EPS (TTM):
-$1.41
Analysts' Opinion
-
Consensus RatingMedicus Pharma has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.67, Medicus Pharma has an estimated upside of 549.07% from its current price of $3.03.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $3.03.
Fair Value
-
According to the consensus of 2 analysts, Medicus Pharma has 549.07% upside to fair value with a price target of $19.67 per share.
MDCX vs. S&P 500
-
Over the past 5 trading days, Medicus Pharma has underperformed the S&P 500 by -8.52% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medicus Pharma does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medicus Pharma has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Medicus Pharma reported revenues of --.
Earnings Growth
-
Medicus Pharma has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Medicus Pharma reported earnings per share of -$0.42.
Enterprise value:
44.3M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-3.40x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$1.1M | -$4M | -$14.5M | -$1.7M | -$5.1M | |
| EBITDA | -$1.1M | -$4.1M | -$13.5M | -$1.7M | -$5.1M | |
| Diluted EPS | -$0.48 | -$1.91 | -$1.41 | -$0.21 | -$0.42 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $35.9K | $654.5K | $5.1M | |
| Total Assets | -- | -- | $35.9K | $985.2K | $5.7M | |
| Current Liabilities | -- | -- | $12.7M | $1.3M | $3.3M | |
| Total Liabilities | -- | -- | $12.7M | $1.6M | $3.5M | |
| Total Equity | -- | -- | -$12.7M | -$610.3K | $2.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1M | -$5.1M | -$13M | -$1.2M | -$3.9M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $5.6M | $16.5M | -- | $3.8M | |
| Free Cash Flow | -$1M | -$5.1M | -$13M | -$1.2M | -$3.9M | |
MDCX
Sector
Market Cap
$48.3M
$34.4M
Price % of 52-Week High
25.25%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-57.2%
-37.36%
Beta (5-Year)
--
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.15
200-day SMA
Sell
Level
$3.79
Bollinger Bands (100)
Sell
Level
2.55 - 4.93
Chaikin Money Flow
Sell
Level
-2.3M
20-day SMA
Buy
Level
$2.94
Relative Strength Index (RSI14)
Sell
Level
46.76
ADX Line
Sell
Level
22.28
Williams %R
Neutral
Level
-68.75
50-day SMA
Sell
Level
$3.87
MACD (12, 26)
Buy
Level
0.84
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Sell
Level
-254.7K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
Stock Forecast FAQ
In the current month, MDCX has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MDCX average analyst price target in the past 3 months is $19.67.
-
Where Will Medicus Pharma Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medicus Pharma share price will rise to $19.67 per share over the next 12 months.
-
What Do Analysts Say About Medicus Pharma?
Analysts are divided on their view about Medicus Pharma share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medicus Pharma is a Sell and believe this share price will drop from its current level to $12.00.
-
What Is Medicus Pharma's Price Target?
The price target for Medicus Pharma over the next 1-year time period is forecast to be $19.67 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MDCX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medicus Pharma is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MDCX?
You can purchase shares of Medicus Pharma via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medicus Pharma shares.
-
What Is The Medicus Pharma Share Price Today?
Medicus Pharma was last trading at $3.23 per share. This represents the most recent stock quote for Medicus Pharma. Yesterday, Medicus Pharma closed at $3.03 per share.
-
How To Buy Medicus Pharma Stock Online?
In order to purchase Medicus Pharma stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
